Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Netaglinide Taj Pharmaceuticals Ltd

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Netaglinide Manufacturers in India Suppliers Netaglinide Dossage Exporters Distributors Netaglinide api active pharmaceuticals ingredients Netaglinide manufacturers Side Effects bulk drugs raw material Dossage Netaglinide companies Side Effects Dossage Importers Netaglinide Dossage Netaglinide Exporters Netaglinide exporters Dossage FDA Dossage Netaglinide Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Netaglinide manufacturing pharmaceutical drugs pharmaceutical intermediates Netaglinide pharmaceutical chemicals pharmaceutical raw materials Netaglinide active pharmaceutical ingredients Netaglinide committee active pharmaceutical ingredients manufacturer Netaglinide Active Pharmaceutical Ingredients manufacturer Netaglinide exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Netaglinide, Netaglinide manufacturer India, Netaglinide product, Netaglinide products, Api preparation, Certificate of Analysis API manufacturer product, Netaglinide anti ulcer product, Certificate of Origin COA Netaglinide COS Netaglinide, pharmaceutical generic, pharmaceutical drug, medical, Netaglinide pharma healthcare, pharma patents, contract MSDS manufacturing Trader Netaglinide pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Netaglinide expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Netaglinide DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Netaglinide ingredients, api, HIV Netaglinide, tablets, capsules, syrup & protein Netaglinide powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Netaglinide gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Netaglinide WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Netaglinide img.







 

 










 

 

HOME >> API >> API List 2 >> Netaglinide >> Dosage

Netaglinide CAS Registry Number 105816-04-4

DOSAGE
Netaglinide CAS Registry Number 105816-04-4

There is no fixed dosage regimen for the management of diabetes mellitus with Netaglinide or any other hypoglycemic agent. In addition to the usual monitoring of urinary glucose, the patient's blood glucose must also be monitored periodically to determine the minimum effective dose for the patient; to detect primary failure, i.e., inadequate lowering of blood glucose at the maximum recommended dose of medication; and to detect secondary failure, i.e., loss of an adequate blood-glucose-lowering response after an initial period of effectiveness. Glycosylated hemoglobin levels may also be of value in monitoring the patient's response to therapy. Short-term administration of Netaglinide may be sufficient during periods of transient loss of control in patients usually controlled well on diet. The recommended starting dose is 5 mg, given before breakfast. Geriatric patients or those with liver disease may be started on 2.5 mg. Dosage adjustments should ordinarily be in increments of 2.55 mg, as determined by blood glucose response. At least several days should elapse between titration steps. If response to a single dose is not satisfactory, dividing that dose may prove effective. The maximum recommended once daily dose is 15 mg. Doses above 15 mg should ordinarily be divided and given before meals of adequate caloric content. The maximum recommended total daily dose is 40 mg.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  



Taj Pharmaceuticals API Logo

Netaglinide

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.